Rocket Pharmaceuticals, Inc

Par Pharmaceuticals Inc, based in Cranbury, NJ, is a highly focused generic pharmaceutical company that has been providing patients and customers with uncompromising quality and value for over 40 years. They are dedicated to delivering high-quality, cost-effective medicines through excellence in innovation, development, manufacturing, and commercialization, specializing in modified-released oral solid dosage forms and non-oral dosage forms. Par Sterile Products, a division of Par Pharmaceuticals, develops, manufactures, and markets a broad portfolio of branded and generic aseptic injectable products. With a sterile manufacturing facility located in Rochester, Michigan, they have gained an unparalleled reputation for high-quality products and regulatory compliance.Generated from the website

Experic LLC is a leading contract development and manufacturing organization (CDMO) and pharmaceutical supply services company based in Cranbury, NJ. They specialize in providing exceptional pharmaceutical development, clinical trial supply, and specialized commercial drug manufacturing services to small, midsize, and specialty pharmaceutical companies. With a team of industry experts and a state-of-the-art facility, Experic offers personalized attention, customized solutions, and unparalleled knowledge and expertise to support every phase of a product's life cycle. From conception to clinical and commercial scale, Experic manages global delivery of high-quality products, including tablets, capsules, and low dose dry powder inhalation. They prioritize timely access to expert resources, expedite clinical trial supplies, and advance commercial drug manufacturing, making them a trusted partner for pharmaceutical companies seeking exceptional service and reliable solutions.Generated from the website

Aurobindo Pharma USA Inc, located in East Windsor, NJ, is a fully integrated pharmaceutical company with a global presence, exporting to over 150 countries worldwide. Committed to quality and safety, Aurobindo Pharma features among the top 2 companies in India in terms of consolidated revenues, with more than 90% of its revenues derived from international operations. With a robust product portfolio and a team of 1,700 expert scientists and analysts globally, Aurobindo Pharma leverages India's competitive cost base to successfully launch affordable products across multiple therapeutic areas and delivery technologies. From discovery to development to commercialization, the company's growth is supported by cost-effective drug development and substantial manufacturing capabilities. Generated from the website